Literature DB >> 31641058

Communicating risk differences between electronic and combusted cigarettes: the role of the FDA-mandated addiction warning and a nicotine fact sheet.

Bo Yang1, Lucy Popova2.   

Abstract

INTRODUCTION: The US Food and Drug Administration requires e-cigarettes to carry a nicotine addiction warning. This research compared the effects of messages communicating comparative risk of electronic and combusted cigarettes (CR messages) with and without the mandated warning and tested the effects of showing a nicotine fact sheet (NFS) before exposure to CR messages with warning.
METHOD: In an online experiment, 1528 US adult smokers were randomised to one of four conditions: (1) three CR messages, (2) three CR messages in condition one with an addiction warning, (3) an NFS followed by the three messages in condition 2 and (4) control messages. Outcomes included message reactions and perceived effectiveness, e-cigarette-related and cigarette-related beliefs and behavioural intentions and nicotine-related beliefs.
RESULTS: CR messages with and without an addiction warning did not differ. The NFS condition produced higher odds of correctly understanding the risk of nicotine and stronger beliefs that switching to e-cigarettes could reduce health risks (response efficacy) than other treatments. Compared with control, all messages made it more likely for people to report e-cigarettes are less harmful than cigarettes and increased response efficacy and switch intentions to e-cigarettes. Only NFS condition increased correct beliefs about the risk of nicotine and self-efficacy about switching to e-cigarettes.
CONCLUSION: Including an addiction warning on CR messages did not reduce intentions to switch to e-cigarettes. Communicating accurate risk of nicotine together with CR messages and addiction warning increased smokers' self-efficacy beliefs about switching completely to e-cigarettes, making it a potentially promising antitobacco communication strategy. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Advertising and Promotion; Electronic nicotine delivery devices; Harm Reduction; Nicotine

Mesh:

Substances:

Year:  2019        PMID: 31641058      PMCID: PMC7174095          DOI: 10.1136/tobaccocontrol-2019-055204

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  36 in total

1.  Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit.

Authors:  Matthew J Carpenter; John R Hughes; Laura J Solomon; Peter W Callas
Journal:  J Consult Clin Psychol       Date:  2004-06

2.  Individual differences in self-concept among smokers attempting to quit: Validation and predictive utility of measures of the smoker self-concept and abstainer self-concept.

Authors:  W G Shadel; R Mermelstein
Journal:  Ann Behav Med       Date:  1996-09

3.  Factors associated with dual use of tobacco and electronic cigarettes: A case control study.

Authors:  Konstantinos E Farsalinos; Giorgio Romagna; Vassilis Voudris
Journal:  Int J Drug Policy       Date:  2015-01-19

4.  Factual text and emotional pictures: overcoming a false dichotomy of cigarette warning labels.

Authors:  Lucy Popova; Daniel Owusu; Desmond Jenson; Torsten B Neilands
Journal:  Tob Control       Date:  2017-04-20       Impact factor: 7.552

Review 5.  The impact of changing attitudes, norms, and self-efficacy on health-related intentions and behavior: A meta-analysis.

Authors:  Paschal Sheeran; Alexander Maki; Erika Montanaro; Aya Avishai-Yitshak; Angela Bryan; William M P Klein; Eleanor Miles; Alexander J Rothman
Journal:  Health Psychol       Date:  2016-06-09       Impact factor: 4.267

6.  Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2016-05-10

7.  Adolescents' receptivity to E-cigarette harms messages delivered using text messaging.

Authors:  Seth M Noar; Jacob A Rohde; Casey Horvitz; Allison J Lazard; Jennifer Cornacchione Ross; Erin L Sutfin
Journal:  Addict Behav       Date:  2018-06-02       Impact factor: 3.913

8.  E-cigarettes Warning Labels and Modified Risk Statements: Tests of Messages to Reduce Recreational Use.

Authors:  Sherri Jean Katz; Bruce Lindgren; Dorothy Hatsukami
Journal:  Tob Regul Sci       Date:  2017-10

9.  Changing Perceptions of Harm of e-Cigarette vs Cigarette Use Among Adults in 2 US National Surveys From 2012 to 2017.

Authors:  Jidong Huang; Bo Feng; Scott R Weaver; Terry F Pechacek; Paul Slovic; Michael P Eriksen
Journal:  JAMA Netw Open       Date:  2019-03-01

10.  Harm perceptions of electronic cigarettes and nicotine: A nationally representative cross-sectional survey of young people in Great Britain.

Authors:  Katherine East; Leonie S Brose; Ann McNeill; Hazel Cheeseman; Deborah Arnott; Sara C Hitchman
Journal:  Drug Alcohol Depend       Date:  2018-10-02       Impact factor: 4.492

View more
  10 in total

Review 1.  Multiple Tobacco Product Use Conceptual Framework: A 2021 Update on Evidence.

Authors:  Dana Rubenstein; Lauren R Pacek; F Joseph McClernon
Journal:  Nicotine Tob Res       Date:  2022-07-13       Impact factor: 5.825

2.  Associations Between Nicotine Knowledge and Smoking Cessation Behaviors Among US Adults Who Smoke.

Authors:  L M Snell; S M Colby; T DeAtley; R Cassidy; J W Tidey
Journal:  Nicotine Tob Res       Date:  2022-04-28       Impact factor: 5.825

3.  Perceptions of Nicotine Reduction Policy in the United States: A Qualitative Study.

Authors:  Katherine C Henderson; Emily E Loud; Hue Trong Duong; Reed M Reynolds; Bo Yang; Charity A Ntansah; David L Ashley; James F Thrasher; Lucy Popova
Journal:  Nicotine Tob Res       Date:  2022-08-06       Impact factor: 5.825

4.  Intentions to Seek Information about E-Cigarettes: Perceived Risk, Efficacy, and Smoking Identity.

Authors:  Bo Yang; Shaohai Jiang
Journal:  J Health Commun       Date:  2021-07-01

5.  Effects of a Nicotine Fact Sheet on Perceived Risk of Nicotine and E-Cigarettes and Intentions to Seek Information About and Use E-Cigarettes.

Authors:  Bo Yang; Daniel Owusu; Lucy Popova
Journal:  Int J Environ Res Public Health       Date:  2019-12-23       Impact factor: 3.390

6.  Examining reactions to smoking and COVID-19 risk messages: An experimental study with people who smoke.

Authors:  Zachary B Massey; Hue Trong Duong; Victoria Churchill; Lucy Popova
Journal:  Int J Drug Policy       Date:  2022-01-31

7.  Do Smokers' Perceptions of the Harmfulness of Nicotine Replacement Therapy and Nicotine Vaping Products as Compared to Cigarettes Influence Their Use as an Aid for Smoking Cessation? Findings from the ITC Four Country Smoking and Vaping Surveys.

Authors:  Hua-Hie Yong; Shannon Gravely; Ron Borland; Coral Gartner; K Michael Cummings; Katherine East; Scott Tagliaferri; Tara Elton-Marshall; Andrew Hyland; Maansi Bansal-Travers; Geoffrey T Fong
Journal:  Nicotine Tob Res       Date:  2022-08-06       Impact factor: 5.825

8.  Effect of brief nicotine corrective messaging on nicotine beliefs in persons who use opioids.

Authors:  Maria A Parker; Jodi E Byers; Andrea C Villanti
Journal:  Exp Clin Psychopharmacol       Date:  2021-07-22       Impact factor: 3.157

9.  LGB Tobacco Control: Do Health Belief Model Constructs Predict Tobacco Use Intentions Differently between LGB and Heterosexual Individuals?

Authors:  Yachao Li; Bo Yang; Bryan Chen
Journal:  Int J Environ Res Public Health       Date:  2021-06-30       Impact factor: 3.390

10.  Will E-Cigarette Modified Risk Messages with a Nicotine Warning Polarize Smokers' Beliefs about the Efficacy of Switching Completely to E-Cigarettes in Reducing Smoking-Related Risks?

Authors:  Bo Yang; Juliana L Barbati; Yunjin Choi
Journal:  Int J Environ Res Public Health       Date:  2021-06-05       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.